Julien Engelhardt
Centre National de la Recherche Scientifique, Hôpital Pellegrin
Papers
2
Total Citations
50
H-Index
2
About
Julien Engelhardt is a leading neurosurgeon and researcher whose work focuses on advancing surgical treatments for movement disorders, particularly Parkinson’s disease. His most impactful contribution is the first prospective randomized trial comparing asleep versus awake deep brain stimulation (DBS) of the subthalamic nucleus, a landmark study published in 2020 that has garnered 47 citations. This work directly addressed a critical clinical question—whether DBS performed under general anesthesia could match the motor outcomes and safety of the traditional awake procedure—providing high-level evidence that has helped shift clinical practice toward less invasive, patient-friendly approaches. Engelhardt has also contributed to the technical literature on stereotactic and navigated brain biopsy techniques, refining the methodology for frame-based and open procedures. His research bridges rigorous clinical trial design with practical neurosurgical innovation, offering clear evidence to guide decision-making in functional neurosurgery. For students and clinicians alike, Engelhardt’s work exemplifies how prospective, controlled studies can resolve long-standing debates and improve patient care in neurosurgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2